Insider’s View: Deciphering Neogenomics Inc. (NEO)’s Financial Health Through Ratios

Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The price of Neogenomics Inc. (NASDAQ: NEO) closed at $13.78 in the last session, down -1.15% from day before closing price of $13.94. In other words, the price has decreased by -$1.15 from its previous closing price. On the day, 1.24 million shares were traded. NEO stock price reached its highest trading level at $13.895 during the session, while it also had its lowest trading level at $13.491.

Ratios:

We take a closer look at NEO’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 1.93 and its Current Ratio is at 2.01. In the meantime, Its Debt-to-Equity ratio is 0.66 whereas as Long-Term Debt/Eq ratio is at 0.44.

On December 29, 2023, BTIG Research reiterated its Buy rating and also upped its target price recommendation from $25 to $21.

Stephens Upgraded its Equal-Weight to Overweight on August 21, 2023, while the target price for the stock was maintained at $18.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Aug 15 ’24 when Olivo Alicia C sold 1,040 shares for $16.05 per share. The transaction valued at 16,695 led to the insider holds 43,813 shares of the business.

ALICIA OLIVO bought 1,040 shares of NEO for $16,453 on Aug 15 ’24. On Aug 15 ’24, another insider, BRUCE K CROWTHER, who serves as the Officer of the company, bought 8,353 shares for $15.95 each.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NEO now has a Market Capitalization of 1766017152 and an Enterprise Value of 1984682368. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.81 while its Price-to-Book (P/B) ratio in mrq is 1.92. Its current Enterprise Value per Revenue stands at 3.159 whereas that against EBITDA is -139.403.

Stock Price History:

The Beta on a monthly basis for NEO is 1.18, which has changed by 0.081632614 over the last 52 weeks, in comparison to a change of 0.3069358 over the same period for the S&P500. Over the past 52 weeks, NEO has reached a high of $21.22, while it has fallen to a 52-week low of $11.65. The 50-Day Moving Average of the stock is -13.60%, while the 200-Day Moving Average is calculated to be -9.56%.

Shares Statistics:

According to the various share statistics, NEO traded on average about 752.40K shares per day over the past 3-months and 874220 shares per day over the past 10 days. A total of 127.37M shares are outstanding, with a floating share count of 126.50M. Insiders hold about 1.29% of the company’s shares, while institutions hold 98.94% stake in the company. Shares short for NEO as of 1726185600 were 5178528 with a Short Ratio of 6.88, compared to 1723680000 on 5015743. Therefore, it implies a Short% of Shares Outstanding of 5178528 and a Short% of Float of 5.609999999999999.

Most Popular